Pravastatin and stroke

Pravastatin may lower stroke risk in patients with coronary artery disease.

August 8, 2000

NEW YORK, August 3 (Praxis Press) The role of cholesterol-lowering therapy in reducing the risk of stroke is unknown and several epidemiological studies have concluded that there is no relation between total cholesterol levels and the risk of stroke. To study this relationship further, White and colleagues examined 9,014 patients with coronary artery disease and randomly assigned them to receive either pravastatin or a placebo. During a mean follow-up period of 6 years, 3.7% of the patients taking pravastatin had a stroke, compared with 4.5% of patients taking a placebo—a 19% reduction in the overall risk of stroke. Nonhemorrhagic stroke occurred in 3.5% of the patients taking pravastatin as compared with 4.4% of the patients taking placebo. Pravastatin has a moderate effect in reducing the risk of stroke in patients with previous myocardial infarction or unstable angina.

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech